Publication | Open Access
Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway
152
Citations
31
References
2017
Year
FFAs upregulate hepatic expression of MPST and subsequently inhibit the CSE/H<sub>2</sub>S pathway, leading to NAFLD. MPST may be a potential therapeutic target for NAFLD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1